☰

Chimera R. Peet, Ph.D. - Publications

Affiliations: 
2009 University of Wisconsin, Madison, Madison, WI 
Area:
Cell Biology, Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Huang S, Peet CR, Saker J, Li C, Armstrong EA, Kragh M, Pedersen MW, Harari PM. Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers. Molecular Cancer Therapeutics. 12: 2772-81. PMID 24130052 DOI: 10.1158/1535-7163.Mct-13-0587  0.384
2013 Huang S, Li C, Armstrong EA, Peet CR, Saker J, Amler LC, Sliwkowski MX, Harari PM. Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation. Cancer Research. 73: 824-33. PMID 23172311 DOI: 10.1158/0008-5472.Can-12-1611  0.479
2011 Brand TM, Dunn EF, Iida M, Myers RA, Kostopoulos KT, Li C, Peet CR, Wheeler DL. Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab. Cancer Biology & Therapy. 12: 436-46. PMID 21725209 DOI: 10.4161/Cbt.12.5.16394  0.455
Show low-probability matches.